{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:15Z","timestamp":1790352495086,"version":"4.1.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017274","name":"CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.pharmthera.2020.107696","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T22:20:02Z","timestamp":1601763602000},"page":"107696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["The potential of artemisinins as anti-obesity agents via modulating the immune system"],"prefix":"10.1016","volume":"216","author":[{"given":"Shengnan","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Kwan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2020.107696_bb0010","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1128\/AAC.38.8.1854","article-title":"Reaction of antimalarial endoperoxides with specific parasite proteins","volume":"38","author":"Asawamahasakda","year":"1994","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nri.2017.99","article-title":"The spectrum of T cell metabolism in health and disease","volume":"18","author":"Bantug","year":"2018","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0020","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0025","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1021\/cr500543f","article-title":"Antimalarials in development in 2014","volume":"114","author":"Barnett","year":"2014","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0030","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.tcb.2020.05.004","article-title":"Endoplasmic reticulum (ER) stress response failure in diseases","volume":"30","author":"Bhattarai","year":"2020","journal-title":"Trends in Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2014.12.030","article-title":"The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo","volume":"42","author":"Blagih","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0040","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.2337\/db08-0604","article-title":"Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals","volume":"57","author":"Boden","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0045","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10637-008-9188-2","article-title":"Artemisinin reduces human melanoma cell migration by down-regulating alpha V beta 3 integrin and reducing metalloproteinase 2 production","volume":"27","author":"Buommino","year":"2009","journal-title":"Investigational New Drugs"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tips.2015.11.011","article-title":"Recent advances in adipose mTOR Signaling and function: Therapeutic prospects","volume":"37","author":"Cai","year":"2016","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0055","doi-asserted-by":"crossref","first-page":"13066","DOI":"10.1002\/anie.201907224","article-title":"Artemisinin-(Iso)quinoline hybrids by C-H activation and click chemistry: Combating multidrug-resistant malaria","volume":"58","author":"Capci","year":"2019","journal-title":"Angewandte Chemie (International Ed. in English)"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0060","doi-asserted-by":"crossref","first-page":"S611","DOI":"10.1080\/21691401.2018.1505739","article-title":"Progress in nano-drug delivery of artemisinin and its derivatives: Towards to use in immunomodulatory approaches","volume":"46","author":"Charlie-Silva","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1039\/B816679J","article-title":"Artemisinin and its derivatives: A novel class of anti-malarial and anti-cancer agents","volume":"39","author":"Chaturvedi","year":"2010","journal-title":"Chemical Society Reviews"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0070","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.biopha.2017.11.010","article-title":"Dihydroartemisinin inhibits ER stress-mediated mitochondrial pathway to attenuate hepatocyte lipoapoptosis via blocking the activation of the PI3K\/Akt pathway","volume":"97","author":"Chen","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0075","first-page":"39","article-title":"Traditional Chinese medicine and related active compounds against hepatitis B virus infection","volume":"4","author":"Cui","year":"2010","journal-title":"Bioscience Trends"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drup.2005.04.003","article-title":"Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy","volume":"8","author":"Efferth","year":"2005","journal-title":"Drug Resistance Updates"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy","volume":"46","author":"Efferth","year":"2017","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0090","first-page":"420","article-title":"The importance of Brown adipose tissue REPLY","volume":"361","author":"Enerback","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0100","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nm.2002","article-title":"Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters","volume":"15","author":"Feuerer","year":"2009","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0105","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1021\/acs.jmedchem.5b01380","article-title":"Artemisinin-derived dimers: Potent antimalarial and anticancer agents","volume":"59","author":"Frohlich","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0110","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1021\/np050074u","article-title":"Antifungal activity of artemisinin derivatives","volume":"68","author":"Galal","year":"2005","journal-title":"Journal of Natural Products"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0115","doi-asserted-by":"crossref","first-page":"48115","DOI":"10.1074\/jbc.M209459200","article-title":"Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex","volume":"277","author":"Gao","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11046-011-9445-3","article-title":"Transcriptomic and proteomic profile of Aspergillus fumigatus on exposure to artemisinin","volume":"172","author":"Gautam","year":"2011","journal-title":"Mycopathologia"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.reprotox.2016.08.003","article-title":"Clinical and non-clinical safety of artemisinin derivatives in pregnancy","volume":"65","author":"Gomes","year":"2016","journal-title":"Reproductive Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0130","doi-asserted-by":"crossref","first-page":"115127","DOI":"10.1016\/j.taap.2020.115127","article-title":"Systematic review of artemisinin embryotoxicity in animals: Implications for malaria control in human pregnancy","volume":"402","author":"Gonzalez","year":"2020","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0135","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0140","doi-asserted-by":"crossref","first-page":"8639523","DOI":"10.1155\/2018\/8639523","article-title":"Antidiabetic and Antiobesity effects of Artemether in db\/db mice","volume":"2018","author":"Guo","year":"2018","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1227568","article-title":"JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation","volume":"339","author":"Han","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1871526513666131129155708","article-title":"Considerations on the mechanism of action of artemisinin antimalarials: Part 1--the \u201ccarbon radical\u201d and \u201cheme\u201d hypotheses","volume":"13","author":"Haynes","year":"2013","journal-title":"Infectious Disorders Drug Targets"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cmdc.201000508","article-title":"Reactions of antimalarial peroxides with each of leucomethylene blue and dihydroflavins: Flavin reductase and the cofactor model exemplified","volume":"6","author":"Haynes","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0160","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrendo.2015.163","article-title":"Endocrine disruptors and obesity","volume":"11","author":"Heindel","year":"2015","journal-title":"Nature Reviews. Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: Controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0170","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: Pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0175","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2017.08.009","article-title":"Foundations of Immunometabolism and implications for metabolic health and disease","volume":"47","author":"Hotamisligil","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0180","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pharmthera.2016.07.002","article-title":"Immune suppressive properties of artemisinin family drugs","volume":"166","author":"Hou","year":"2016","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032424","article-title":"SM934 treated lupus-prone NZB x NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development","volume":"7","author":"Hou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.canlet.2013.09.035","article-title":"Dihydroartemisinin induces autophagy by suppressing NF-kappaB activation","volume":"343","author":"Hu","year":"2014","journal-title":"Cancer Letters"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0200","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027326","article-title":"Risk models and scores for metabolic syndrome: Systematic review protocol","volume":"9","author":"Ibrahim","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0205","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbrc.2016.04.109","article-title":"Artesunate inhibits adipogeneis in 3T3-L1 preadipocytes by reducing the expression and\/or phosphorylation levels of C\/EBP-alpha, PPAR-gamma, FAS, perilipin a, and STAT-3","volume":"474","author":"Jang","year":"2016","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"673\u2013689","key":"10.1016\/j.pharmthera.2020.107696_bb0210","article-title":"Elucidating the molecular basis for inhibitory neurotransmission regulation by Artemisinins","volume":"101","author":"Kasaragod","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0215","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.trsl.2015.08.011","article-title":"Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction","volume":"167","author":"Khodabandehloo","year":"2016","journal-title":"Translational Research"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0220","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05920","article-title":"The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells","volume":"4","author":"Khor","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0225","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1021\/jm990014j","article-title":"Synthesis and antimalarial activity of cyclic peroxides, 1,2,4,5, 7-pentoxocanes and 1,2,4,5-tetroxanes","volume":"42","author":"Kim","year":"1999","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0230","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s12272-017-0965-3","article-title":"Novel anti-adipogenic activity of anti-malarial amodiaquine through suppression of PPARgamma activity","volume":"40","author":"Kim","year":"2017","journal-title":"Archives of Pharmacal Research"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0235","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): An antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0240","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40264-014-0261-9","article-title":"Treating severe malaria in pregnancy: A review of the evidence","volume":"38","author":"Kovacs","year":"2015","journal-title":"Drug Safety"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0245","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1159\/000489982","article-title":"Artesunate attenuates pro-inflammatory cytokine release from macrophages by inhibiting TLR4-mediated Autophagic activation via the TRAF6-Beclin1-PI3KC3 pathway","volume":"47","author":"Kuang","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0250","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejmech.2018.12.007","article-title":"Current scenario of artemisinin and its analogues for antimalarial activity","volume":"163","author":"Kumari","year":"2019","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0255","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chemphyslip.2009.04.005","article-title":"Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid","volume":"160","author":"Kumura","year":"2009","journal-title":"Chemistry and Physics of Lipids"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0260","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrd.2016.75","article-title":"Targeting adipose tissue in the treatment of obesity-associated diabetes","volume":"15","author":"Kusminski","year":"2016","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0265","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"Lai","year":"2013","journal-title":"Investigational New Drugs"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0270","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.intimp.2007.10.024","article-title":"Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation","volume":"8","author":"Li","year":"2008","journal-title":"International Immunopharmacology"},{"issue":"86\u2013100","key":"10.1016\/j.pharmthera.2020.107696_bb0275","article-title":"Artemisinins target GABAA receptor Signaling and impair alpha cell identity","volume":"168","author":"Li","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0285","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/10915810591007201","article-title":"Toxicokinetics and hydrolysis of artelinate and artesunate in malaria-infected rats","volume":"24","author":"Li","year":"2005","journal-title":"International Journal of Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0290","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.intimp.2013.03.011","article-title":"Evaluation of the immunosuppressive activity of artesunate in vitro and in vivo","volume":"16","author":"Li","year":"2013","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0295","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebiom.2016.11.026","article-title":"Preclinical efficacy and safety assessment of Artemisinin-chemotherapeutic agent conjugates for ovarian Cancer","volume":"14","author":"Li","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0300","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.trsl.2012.06.001","article-title":"Inhibitory effect of the antimalarial agent artesunate on collagen-induced arthritis in rats through nuclear factor kappa B and mitogen-activated protein kinase signaling pathway","volume":"161","author":"Li","year":"2013","journal-title":"Translational Research"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0305","first-page":"1","article-title":"Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma","volume":"41","author":"Li","year":"2020","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0310","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fncel.2018.00108","article-title":"Artemisinin prevents glutamate-induced neuronal cell death via Akt pathway activation","volume":"12","author":"Lin","year":"2018","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0315","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.cell.2014.07.011","article-title":"Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate","volume":"158","author":"Lisewski","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0320","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/cr.2016.108","article-title":"Artemisinin derivatives prevent obesity by inducing browning of WAT and enhancing BAT function","volume":"26","author":"Lu","year":"2016","journal-title":"Cell Research"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0325","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0330","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4155\/fmc-2018-0337","article-title":"Artemisinin and its derivatives; ancient tradition inspiring the latest therapeutic approaches against malaria","volume":"11","author":"Martino","year":"2019","journal-title":"Future Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0335","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nature14412","article-title":"A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria","volume":"520","author":"Mbengue","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0340","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI88876","article-title":"Role of innate and adaptive immunity in obesity-associated metabolic disease","volume":"127","author":"McLaughlin","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0345","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-6851(91)90062-B","article-title":"Artemisinin (qinghaosu): The role of intracellular hemin in its mechanism of antimalarial action","volume":"49","author":"Meshnick","year":"1991","journal-title":"Molecular and Biochemical Parasitology"},{"issue":"218\u2013225","key":"10.1016\/j.pharmthera.2020.107696_bb0350","article-title":"Artemether does not turn alpha cells into beta cells","volume":"27","author":"van der Meulen","year":"2018","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0355","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1021\/jp0574089","article-title":"Modeling the decomposition mechanism of artemisinin","volume":"110","author":"Moles","year":"2006","journal-title":"The Journal of Physical Chemistry. A"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0360","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: Nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0365","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2008.09.023","article-title":"Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis","volume":"274","author":"Nakase","year":"2009","journal-title":"Cancer Letters"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0370","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2016.10.015","article-title":"Obesity: Current and potential pharmacotherapeutics and targets","volume":"170","author":"Narayanaswami","year":"2017","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0375","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00003088-200039040-00002","article-title":"Pharmacokinetics of artemisinin-type compounds","volume":"39","author":"Navaratnam","year":"2000","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0380","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the global burden of disease study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0385","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm.3614","article-title":"A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice","volume":"20","author":"Oh","year":"2014","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0390","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1016\/j.bmc.2014.07.007","article-title":"A semi-synthetic derivative of artemisinin, artesunate inhibits prostaglandin E2 production in LPS\/IFNgamma-activated BV2 microglia","volume":"22","author":"Okorji","year":"2014","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0395","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3389\/fphar.2018.00562","article-title":"Curcumin-Artesunate based polymeric nanoparticle; Antiplasmodial and toxicological evaluation in murine model","volume":"9","author":"Oyeyemi","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0400","doi-asserted-by":"crossref","first-page":"19383","DOI":"10.1074\/jbc.274.27.19383","article-title":"Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite","volume":"274","author":"Pandey","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0405","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.2337\/db15-1156","article-title":"IKKbeta is essential for adipocyte survival and adaptive adipose Remodeling in obesity","volume":"65","author":"Park","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0410","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.3082","article-title":"An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice","volume":"19","author":"Reilly","year":"2013","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0415","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.2147\/DDDT.S118116","article-title":"Endoperoxide antimalarials: Development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold","volume":"10","author":"Rudrapal","year":"2016","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0420","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2011.06.044","article-title":"Artemisinins and immune system","volume":"668","author":"Shakir","year":"2011","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0425","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/ni.3709","article-title":"The metabolic ER stress sensor IRE1alpha suppresses alternative activation of macrophages and impairs energy expenditure in obesity","volume":"18","author":"Shan","year":"2017","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0430","first-page":"398","article-title":"Immunosuppressive action of Qinghaosu","volume":"27","author":"Shen","year":"1984","journal-title":"Scientia Sinica. Series B"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0435","doi-asserted-by":"crossref","first-page":"435713","DOI":"10.1155\/2015\/435713","article-title":"Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives","volume":"2015","author":"Shi","year":"2015","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0440","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0445","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.phrs.2018.09.002","article-title":"Resolving neuroinflammation, the therapeutic potential of the anti-malaria drug family of artemisinin","volume":"136","author":"Shi","year":"2018","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0450","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0455","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrgentox.2014.11.001","article-title":"The antimalarial agent artesunate causes sperm DNA damage and hepatic antioxidant defense in mice","volume":"777","author":"Singh","year":"2015","journal-title":"Mutation Research, Genetic Toxicology and Environmental Mutagenesis"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0465","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(01)00240-9","article-title":"Obesity and the regulation of energy balance","volume":"104","author":"Spiegelman","year":"2001","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107696_bb0470","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2337\/db18-1254","article-title":"Evaluation of the genetic association between adult obesity and neuropsychiatric disease","volume":"68","author":"Stahel","year":"2019","journal-title":"Diabetes."},{"key":"10.1016\/j.pharmthera.2020.107696_bb0475","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbrc.2005.07.109","article-title":"Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species","volume":"335","author":"Stentz","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0480","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.coph.2017.08.006","article-title":"Adipose tissue inflammation in obesity: A metabolic or immune response?","volume":"37","author":"Stolarczyk","year":"2017","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0485","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1126\/science.271.5246.219","article-title":"Plasmodium hemozoin formation mediated by histidine-rich proteins","volume":"271","author":"Sullivan","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0490","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.bbamcr.2017.04.014","article-title":"The antimalarial drug artemisinin induces an additional, Sod1-supressible anti-mitochondrial action in yeast","volume":"1864","author":"Sun","year":"2017","journal-title":"Biochimica et Biophysica Acta - Molecular Cell Research"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0495","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/med.21580","article-title":"Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives","volume":"39","author":"Sun","year":"2019","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0500","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.1074\/jbc.M117.779108","article-title":"Deletion of interleukin 1 receptor-associated kinase 1 (Irak1) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscle","volume":"292","author":"Sun","year":"2017","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0505","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41419-019-1847-z","article-title":"Inhibition of IRE1alpha RNase activity reduces NLRP3 inflammasome assembly and processing of pro-IL1beta","volume":"10","author":"Talty","year":"2019","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0510","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/CAD.0b013e32834f6ea8","article-title":"Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes","volume":"23","author":"Tin","year":"2012","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0515","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine","volume":"17","author":"Tu","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0520","doi-asserted-by":"crossref","first-page":"10741","DOI":"10.1073\/pnas.0603509103","article-title":"Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance","volume":"103","author":"Tuncman","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0525","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02779","article-title":"Identification of an antimalarial synthetic trioxolane drug development candidate","volume":"430","author":"Vennerstrom","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0530","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneph.2015.175","article-title":"Innate immunity in diabetes and diabetic nephropathy","volume":"12","author":"Wada","year":"2016","journal-title":"Nature Reviews. Nephrology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0535","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: From stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0540","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s10753-015-0172-7","article-title":"Artesunate attenuates lipopolysaccharide-stimulated Proinflammatory responses by suppressing TLR4, MyD88 expression, and NF-kappaB activation in microglial cells","volume":"38","author":"Wang","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0545","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11427-014-4736-9","article-title":"Artemisinin mimics calorie restriction to extend yeast lifespan via a dual-phase mode: A conclusion drawn from global transcriptome profiling","volume":"58","author":"Wang","year":"2015","journal-title":"Science China. Life Sciences"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0550","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.822","article-title":"Artemisinin mimics calorie restriction to trigger mitochondrial biogenesis and compromise telomere shortening in mice","volume":"3","author":"Wang","year":"2015","journal-title":"PeerJ"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0555","first-page":"990","article-title":"A temporizing solution to \u201cArtemisinin resistance\u201d. Reply","volume":"381","author":"Wang","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0560","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMp1901233","article-title":"A temporizing solution to \u201cArtemisinin resistance\u201d","volume":"380","author":"Wang","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0565","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tips.2017.03.007","article-title":"Unpacking \u201cArtemisinin Resistance\u201d","volume":"38","author":"Wang","year":"2017","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30223-3","article-title":"Malaria eradication","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0580","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.bjp.0707137","article-title":"Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation","volume":"150","author":"Wang","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0585","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nature17041","article-title":"Protein misfolding in the endoplasmic reticulum as a conduit to human disease","volume":"529","author":"Wang","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0590","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00280-011-1643-7","article-title":"Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-kappaB pathway","volume":"68","author":"Wang","year":"2011","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0595","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejps.2013.08.003","article-title":"Effects of artesunate and ursolic acid on hyperlipidemia and its complications in rabbit","volume":"50","author":"Wang","year":"2013","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0600","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0605","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: A glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0610","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1074\/jbc.M804491200","article-title":"Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression","volume":"284","author":"Willoughby","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0615","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/med.21446","article-title":"Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action","volume":"37","author":"Wong","year":"2017","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0620","first-page":"101","article-title":"Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer","volume":"27","author":"Wu","year":"2012","journal-title":"Oncology Reports"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0625","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cca.2012.12.007","article-title":"Role of leptin and adiponectin in insulin resistance","volume":"417","author":"Yadav","year":"2013","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0630","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3892\/mmr.2016.5966","article-title":"Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease","volume":"15","author":"Yan","year":"2017","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0635","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4049\/jimmunol.1000021","article-title":"Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: Implications for systemic inflammation and insulin resistance","volume":"185","author":"Yang","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0640","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0006-2952(94)90287-9","article-title":"Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure","volume":"48","author":"Yang","year":"1994","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0645","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-017-0436-9","article-title":"Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: From pathophysiology to treatment","volume":"10","author":"Yoshida","year":"2017","journal-title":"Journal of Hematology & Oncology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0650","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-8587(15)00261-2","article-title":"The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: A randomised trial","volume":"3","author":"de Zeeuw","year":"2015","journal-title":"The Lancet Diabetes and Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0655","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.redox.2018.07.025","article-title":"Artesunate-induced mitophagy alters cellular redox status","volume":"19","author":"Zhang","year":"2018","journal-title":"Redox Biology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0660","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.4049\/jimmunol.1200919","article-title":"Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway","volume":"189","author":"Zhao","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0665","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2016.05.023","article-title":"Artemisinin conferred ERK mediated neuroprotection to PC12 cells and cortical neurons exposed to sodium nitroprusside-induced oxidative insult","volume":"97","author":"Zheng","year":"2016","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0670","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/acschembio.5b01043","article-title":"Profiling of multiple targets of Artemisinin activated by Hemin in Cancer cell proteome","volume":"11","author":"Zhou","year":"2016","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/j.pharmthera.2020.107696_bb0675","doi-asserted-by":"crossref","first-page":"1489050","DOI":"10.1155\/2016\/1489050","article-title":"The potential therapeutic effects of Artesunate on stroke and other central nervous system diseases","volume":"2016","author":"Zuo","year":"2016","journal-title":"BioMed Research International"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820302266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820302266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:08:05Z","timestamp":1759010885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820302266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":132,"alternative-id":["S0163725820302266"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107696","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of artemisinins as anti-obesity agents via modulating the immune system","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107696"}}